Jennifer L. Goldman

The Francis Crick Institute

Papers

1

Total Citations

14

H-Index

1

About

Dr. Jennifer L. Goldman is a leading infectious disease researcher whose work bridges clinical virology and public health preparedness. Her most-cited paper, "Scalable and Resilient SARS-CoV-2 testing in an Academic Centre" (2020, 14 citations), addresses a critical bottleneck during the COVID-19 pandemic: the shortage of diagnostic tests for healthcare workers. This study demonstrated how academic medical centers could rapidly scale up testing capacity while maintaining resilience against supply chain disruptions—a contribution that helped protect frontline staff and informed institutional pandemic response protocols. Beyond this landmark work, Dr. Goldman's research focuses on optimizing diagnostic strategies for emerging pathogens, antimicrobial stewardship, and the intersection of viral epidemiology with healthcare system logistics. Her impact lies not only in her citation record but in the practical, life-saving applications of her findings: enabling faster outbreak detection, preserving scarce resources, and safeguarding healthcare workers during crises. For students and researchers, Dr. Goldman exemplifies how rigorous translational science can directly address urgent public health challenges, turning institutional innovation into global preparedness frameworks.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Scalable and Resilient SARS-CoV-2 testing in an Academic Centre
14 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 79
🏛 Institutions: The Francis Crick Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago